Document is current
Any future updates will be listed below
-
Authors
Huggins, Ashley A. http://orcid.org/0000-0001-7936-2116
Baird, C. Lexi http://orcid.org/0000-0002-1117-970X
Briggs, Melvin
Laskowitz, Sarah
Hussain, Ahmed http://orcid.org/0009-0005-8761-7525
Fouda, Samar
Haswell, Courtney
Sun, Delin
Salminen, Lauren E.
Jahanshad, Neda
Thomopoulos, Sophia I.
Veltman, Dick J.
Frijling, Jessie L.
Olff, Miranda http://orcid.org/0000-0003-1016-9515
van Zuiden, Mirjam
Koch, Saskia B. J.
Nawjin, Laura http://orcid.org/0000-0001-7183-8933
Wang, Li http://orcid.org/0000-0002-1459-3412
Zhu, Ye
Li, Gen
Stein, Dan J. http://orcid.org/0000-0001-7218-7810
Ipser, Jonathan
Seedat, Soraya http://orcid.org/0000-0002-5118-786X
du Plessis, Stefan
van den Heuvel, Leigh L.
Suarez-Jimenez, Benjamin
Zhu, Xi http://orcid.org/0000-0002-9724-7231
Kim, Yoojean
He, Xiaofu
Zilcha-Mano, Sigal http://orcid.org/0000-0002-5645-4429
Lazarov, Amit http://orcid.org/0000-0002-2811-2739
Neria, Yuval
Stevens, Jennifer S. http://orcid.org/0000-0003-4674-0314
Ressler, Kerry J. http://orcid.org/0000-0002-5158-1103
Jovanovic, Tanja
van Rooij, Sanne J. H. http://orcid.org/0000-0002-0160-7248
Fani, Negar http://orcid.org/0000-0002-7720-252X
Hudson, Anna R. http://orcid.org/0000-0002-5752-7888
Mueller, Sven C. http://orcid.org/0000-0003-1661-3840
Sierk, Anika http://orcid.org/0000-0002-1396-8075
Manthey, Antje
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Daniels, Judith K.
Schmahl, Christian
Herzog, Julia I. http://orcid.org/0000-0001-8326-5466
Říha, Pavel http://orcid.org/0000-0002-1322-2038
Rektor, Ivan http://orcid.org/0000-0002-9635-7404
Lebois, Lauren A. M. http://orcid.org/0000-0001-5816-9181
Kaufman, Milissa L.
Olson, Elizabeth A.
Baker, Justin T. http://orcid.org/0000-0002-6629-2195
Rosso, Isabelle M.
King, Anthony P.
Liberzon, Isreal http://orcid.org/0000-0002-4990-556X
Angstadt, Mike http://orcid.org/0000-0003-4870-7649
Davenport, Nicholas D.
Sponheim, Scott R. http://orcid.org/0000-0002-2782-0856
Disner, Seth G. http://orcid.org/0000-0003-3635-9421
Straube, Thomas
Hofmann, David
Qi, Rongfeng http://orcid.org/0000-0002-9981-9918
Lu, Guang Ming http://orcid.org/0000-0003-4913-2314
Baugh, Lee A.
Forster, Gina L.
Simons, Raluca M.
Simons, Jeffrey S.
Magnotta, Vincent A. http://orcid.org/0000-0001-8639-5354
Fercho, Kelene A.
Maron-Katz, Adi
Etkin, Amit
Cotton, Andrew S.
O’Leary, Erin N. http://orcid.org/0000-0002-2993-7003
Xie, Hong http://orcid.org/0000-0002-5762-6456
Wang, Xin http://orcid.org/0000-0003-1524-2902
Quidé, Yann http://orcid.org/0000-0002-8569-7139
El-Hage, Wissam
Lissek, Shmuel
Berg, Hannah
Bruce, Steven http://orcid.org/0000-0002-5807-4382
Cisler, Josh
Ross, Marisa
Herringa, Ryan J. http://orcid.org/0000-0002-1936-7959
Grupe, Daniel W. http://orcid.org/0000-0003-4927-7572
Nitschke, Jack B.
Davidson, Richard J. http://orcid.org/0000-0002-8506-4964
Larson, Christine L.
deRoon-Cassini, Terri A. http://orcid.org/0000-0002-9485-0625
Tomas, Carissa W. http://orcid.org/0000-0002-9199-8632
Fitzgerald, Jacklynn M.
Blackford, Jennifer Urbano http://orcid.org/0000-0002-0261-4845
Olatunji, Bunmi O.
Kremen, William S. http://orcid.org/0000-0002-8629-5609
Lyons, Michael J.
Franz, Carol E. http://orcid.org/0000-0002-8987-1755
Gordon, Evan M. http://orcid.org/0000-0002-2276-5237
May, Geoffrey
Nelson, Steven M.
Abdallah, Chadi G. http://orcid.org/0000-0001-5783-6181
Levy, Ifat http://orcid.org/0000-0001-7851-9070
Harpaz-Rotem, Ilan http://orcid.org/0000-0002-6066-9406
Krystal, John H. http://orcid.org/0000-0001-6952-1726
Dennis, Emily L. http://orcid.org/0000-0001-7112-4009
Tate, David F. http://orcid.org/0000-0003-0213-1920
Cifu, David X.
Walker, William C.
Wilde, Elizabeth A.
Harding, Ian H.
Kerestes, Rebecca
Thompson, Paul M.
Morey, Rajendra
- License Information
-
More Information
Article History
Received: 10 June 2023
Revised: 22 November 2023
Accepted: 27 November 2023
First Online: 10 January 2024
Competing interests
: NJ received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the content of this manuscript. PMT received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the topic of this manuscript. CS is consultant for Boehringer Ingelheim International GmbH. LAML reports unpaid membership on the Scientific Committee for the International Society for the Study of Trauma and Dissociation (ISSTD), grant support from the National Institute of Mental Health, K01 MH118467, and spousal IP payments from Vanderbilt University for technology licensed to Acadia Pharmaceuticals unrelated to the present work. ISSTD and NIMH were not involved in the analysis or preparation of the manuscript. WEH is affiliated with Air Liquide, Boehringer Ingelheim, CHUGAI, EISAI, Jazz Pharmaceuticals, Janssen, Lundbeck, Novartis, Otsuka, UCB but nothing related to this work. RJD is the founder and president of, and serves on the board of directors for, the non-profit organization Healthy Minds Innovations, Inc. CGA has served as a consultant, speaker and/or on advisory boards for FSV7, Lundbeck, Psilocybin Labs, Genentech, Janssen and Aptinyx; served as editor of Chronic Stress for Sage Publications, Inc; and filed a patent for using mTOR inhibitors to augment the effects of antidepressants (filed on August 20, 2018). JHK is a consultant for AbbVie, Inc., Amgen, Astellas Pharma Global Development, Inc., AstraZeneca Pharmaceuticals, Biomedisyn Corporation, Bristol-Myers Squibb, Eli Lilly and Company, Euthymics Bioscience, Inc., Neurovance, Inc., FORUM Pharmaceuticals, Janssen Research & Development, Lundbeck Research USA, Novartis Pharma AG, Otsuka America Pharmaceutical, Inc., Sage Therapeutics, Inc., Sunovion Pharmaceuticals, Inc., and Takeda Industries; is on the Scientific Advisory Board for Lohocla Research Corporation, Mnemosyne Pharmaceuticals, Inc., Naurex, Inc., and Pfizer; is a stockholder in Biohaven Pharmaceuticals; holds stock options in Mnemosyne Pharmaceuticals, Inc.; holds patents for Dopamine and Noradrenergic Reuptake Inhibitors in Treatment of Schizophrenia, US Patent No. 5,447,948 (issued September 5, 1995), and Glutamate Modulating Agents in the Treatment of Mental Disorders, U.S. Patent No. 8,778,979 (issued July 15, 2014); and filed a patent for Intranasal Administration of Ketamine to Treat Depression. U.S. Application No. 14/197,767 (filed on March 5, 2014); US application or Patent Cooperation Treaty international application No. 14/306,382 (filed on June 17, 2014). Filed a patent for using mTOR inhibitors to augment the effects of antidepressants (filed on August 20, 2018). A version of this manuscript was uploaded to the biorxiv.org preprint server ().
